cbdMD beats Street expectations in 2Q, with revenue boosts and strong sales growth
Thursday, 16 May 2019 cbdMD Inc (NYSEAMERICAN:YCBD) posted fiscal second-quarter revenues that came in ahead of expectation. The US cannabis company saw revenue jump 84% to $5.7 million, topping Street expectations of $3.2 million. Working capital increased to $12.3 million from $10.8 million in the prior quarter. “Our goal is to build cbdMD into the most recognized CBD brand in the America,” Martin A. Sumichrast said. “Our strong second quarter results place us in a great position to accomplish this goal. Our e-commerce sales platform remains strong and has accounted for over 70% of our total net sales. On a store count basis, we have grown from under 600 doors in December 2018 to over 2,000 currently, and we continue to build momentum.” READ: cbdMD stock slips on public offering The company also set aside $30.9 million in a contingent liability related to the acquisition of the cbdMD brand in December, back when the company was still known as Level Brands. Excluding the contingent liability, the Charlotte-based company posted a loss of $900,000. The cbdMD brand includes CBD gummies, tinctures, topical, bath bombs, oils and pet products. Shares slipped 2.5% to close at $6.19. Contact Andrew Kessel at [email protected] Follow him on Twitter @andrew_kessel
The U.S. market is still up considerably in 2019. And as the economy clearly looks to be closer to the end of its current boom than the middle of it, some investors may want to consider defensive stocks, as the S&P 500 is up 14.6% year-to-date. Enter Procter and Gamble "At Procter and Gamble we see...
What's going on in the markets? Jim Cramer breaks down some of the biggest stories driving the markets Friday. The Jobs Report The jobs report number came in shy of expectations. The U.S. economy was..